28 Jul 2026Open access
Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelinationPublisher siteInflammopharmacology, Multiple Sclerosis Research Studies
UniversitiesRehab M. El‐Sayed
Active, last published 2026
In parkinson's disease mechanisms and treatments
Rehab M.
El‐Sayed
Scholar“Research focused on Parkinson's Disease Mechanisms and Treatments and adjacent fields.”
Arish University
Claim Your Profile14
H-index
450
Citations
Rehab has not officially claimed their profile. If you are Rehab, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ehab M. El‐Sayed is a researcher working on Parkinson's Disease Mechanisms and Treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Rehab's work has been cited 450 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Parkinson's Disease Mechanisms and Treatments×3Autophagy in Disease and Therapy×3Sirtuins and Resveratrol in Medicine×3Tryptophan and brain disorders×3Chemotherapy-induced organ toxicity mitigation×3
04 · Where I am
Affiliations
Affiliation on published researchArish UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works7 Jul 2025Open access5cites
Crosstalk between ferroptosis and NLRP3, a possible therapeutic target in experimentally-induced rheumatoid arthritis: role of P2Y12R inhibition in modulating P53/SLC7A11/ALOX15 signalingPublisher siteInflammopharmacology, Ferroptosis and cancer prognosis
19 Feb 202512cites
Mitigating seizure-induced cognitive deficits in mice induced with pentylenetetrazol by roflumilast through targeting the NLRP3 inflammasome/BDNF/SIRT3 pathway and regulating ferroptosisPublisher siteLife Sciences, Tryptophan and brain disorders
13 Feb 20252cites
Probiotics reverse gut dysbiosis and memory impairment associated with esomeprazole use in chronically stressed rats: A significant neuroprotective role for cholecystokininPublisher siteInternational Immunopharmacology, Gastrointestinal motility and disorders
28 Jan 2025Open access2cites
Chronic Unpredictable Mild Stress Induced Cognitive Impairment: AMPK/mTOR Autophagic SignalingPublisher siteSINAI International Scientific Journal., Autophagy in Disease and Therapy
27 Aug 2024Open access7cites
Computational Analysis and Experimental Data Exploring the Role of Hesperetin in Ameliorating ADHD and SIRT1/Nrf2/Keap1/OH-1 SignalingPublisher siteInternational Journal of Molecular Sciences, Attention Deficit Hyperactivity Disorder
1 Mar 2024Open access9cites
Computational and Experimental Approaches Exploring the Role of Hesperetin in Improving Autophagy in Rat Diabetic RetinopathyPublisher siteBiomedicines, Retinal Diseases and Treatments
23 Nov 2023Open access9cites
Marula oil nanoemulsion improves motor function in experimental parkinsonism via mitigation of inflammation and oxidative stressPublisher siteFrontiers in Pharmacology, Parkinson's Disease Mechanisms and Treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Rehab?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you